drugset / Trial / NCT04940845
Comparing of the Pharmacokinetic, Safety and Immunogenicity of HS-20090-2 Injection and Prolia® in Healthy Adults
RandomizedParallel-groupSingle-blindPrevention
Summary
A randomized, single-blind and parallel group study to compare the pharmacokinetic, safety and immunogenicity of HS-20090-2 60mg#1ml#and Prolia® in healthy adults.
Timeline
- Start
- 2021-07-26
- Primary completion
- 2022-06
- Completion
- 2022-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Denosumab | Monoclonal antibody | 60 mg | Subcutaneous |
| Subject | HS-20090-2 | Unknown | 60 mg | Subcutaneous |